Drs Noor and Lamb discuss mechanisms of action of biologics and JAK inhibitors and the importance of patient communication while selecting AD treatments.
Drs Lamb, Noor, and Bhatia discuss their approach to selecting treatment in light of recent AD approvals.
Drs Noor and Lamb highlight the importance of frank discussion of adverse effects of atopic dermatitis treatments with patients.
Drs Bhatia, Lamb and Noor talk about the importance of building trust with patients and highlight topics to discuss with patients and parents.
Dermatology experts discuss strategies to increase awareness of advances in AD in patients with SOC.
Drs. Neal Bhatia and Angela Lamb provide an overview of atopic dermatitis and its prevalence in patients with skin of color (SOC).
A better understanding of this atopic diathesis and the atopic march often seen in pediatric patients is necessary to optimally treat and manage the patient population, ideally in a multidisciplinary setting.
In this epsiode, Raj Chovatiya, MD, PhD, and assistant professor of dermatology and director of the Center for Ecezma and Itch at the Northwestern University Feinberg School of Medicine, discusses the changing field of atopic dermatitis, the importance of JAK inhibitors, and the treatment options he looks forward to.
At the SPD 2022 47th Annual Meeting in Indianapolis, Indiana, Candrice Heath shares her takeaways "Atopic dermatitis in skin of color."
At the SPD 2022 47th Annual Meeting in Indianapolis, Candrice R. Heath, MD, FAAP, FAAD shares compelling best practices for treating patients of color with this condition.